الفهرس 
Chapter 1: HyperuricemiaOnly 14 pages are availabe for public view
 |  | from | 97 |  |  |
| | | from | 97 | | |
Abstract
The prevalence of hyperuricemia is obviously rising during the last years and decades. Musculoskletalultrasound (MSUS) is one of the new imaging modalities in the diagnosis and management of the hyperuricemic and gouty patients. In the past, the relation between the hyperuricemia and the cardiovascular diseases (CVD) was not well established. Recently, association between hyperuricemia and CVD as stroke and ischemic heart disease became more prominent. The relation between the hyperuricemic MSUS signs and the CVD risk isn’t yet well established.
Objectives:
This study aims to clarify the possible relation between the hyperuricemic MSUS signs and the CVD risk. 66 hyperuricemic patients were assessed clinically, laboratory and by MSUS. These patients were subdivided into 2 groups: symptomatic and asymptomatic hyperuricemia and each group contained 33 patients. 6 joints were MSUS examined in each patient including both knees, both ankles and both first metatarsophalangeal joints (1st MTPs) searching for the specific signs of hyperuricemia and gout. Cardiovascular risk was assessed for each patient using 2 of the commonest and internationally approved cardiovascular risk scoring systems: Systematic COronary Risk Evaluation (SCORE) of the European Society of Cardiology (ESC) and Atherosclerotic Cardiovascular Disease (ASCVD) of American College of Cardiology (ACC).